GO
Loading...

CNBC News Corrections

  Thursday, 24 Apr 2014 | 12:44 PM ET

This version corrected the spelling of the last name of JMP Securities' Alex Gauna.

»Read more
  Thursday, 24 Apr 2014 | 9:06 AM ET

This version corrected that Caterpillar stock rose in premarket trading.

»Read more
  Thursday, 24 Apr 2014 | 5:43 AM ET

This article has been updated to reflect that 17 percent of Novozymes' sales were in its bioenergy division, in the first quarter of 2014.

»Read more
  Tuesday, 22 Apr 2014 | 5:18 AM ET

This story has been updated to reflect that Novartis' animal health division will be sold for around $5.4 billion.

»Read more
  Thursday, 17 Apr 2014 | 12:58 PM ET

This story has been updated to reflect the correct courtroom for Chatwal's appearance.

»Read more
  Wednesday, 16 Apr 2014 | 5:38 PM ET

This story has been updated with the correct spelling for singer Kanye West.

»Read more
  Wednesday, 16 Apr 2014 | 4:13 AM ET

This story has been updated with Peter Sullivan's correct first name

»Read more
  Tuesday, 15 Apr 2014 | 5:34 PM ET

Yahoo reported first-quarter revenue of $1.09 billion. This article was corrected to reflect that fact.

»Read more
  Tuesday, 15 Apr 2014 | 7:53 AM ET

An earlier version of this story misidentified the shale formation nearest to Oklahoma. It has been corrected.

»Read more
  Tuesday, 15 Apr 2014 | 6:04 AM ET

This story has been corrected to reflect that the drop in March new home sales was 83 percent from a year earlier

»Read more

Most Popular Video

Thursday, 24 Apr 2014 | 4:03 PM ET

Microsoft is reporting Q3 EPS of $0.68 on revenue of $20.40 billion, with CNBC's Josh Lipton.

Thursday, 24 Apr 2014 | 12:41 PM ET

CNBC's Meg Tirrell reports a Cowen analyst is suggesting Allergan buy ADHD drug maker Shire. The FMHR traders, provide perspective.

Thursday, 24 Apr 2014 | 2:30 PM ET

Sell in May? It's an old cliché but the problem is it's sometimes right! But earnings keep rolling in better than expected. CNBC's Patti Domm explains.